---
figid: PMC9013399__41598_2022_10476_Fig1_HTML
figtitle: Significance of NAD + metabolites and nicotinamide N-methyltransferase in
  chronic kidney disease
organisms:
- NA
pmcid: PMC9013399
filename: 41598_2022_10476_Fig1_HTML.jpg
figlink: /pmc/articles/PMC9013399/figure/Fig1/
number: F1
caption: NNMT regulates NAD + and methionine metabolism. NAD + -consuming enzymes
  (Sirtuins, PARPs, cADPR synthases) degrade NAD + to NAM. NAM is converted to NMN
  by NAMPT for reuse in NAD + biosynthesis (salvage pathway). Otherwise, NAM is metabolized
  to MNA by NNMT. NNMT uses SAM as a methyl donor and yields MNA and SAH from NAM.
  N-Me-2PY and N-Me-4PY are the major final NAM metabolites. In addition to the salvage
  pathway, there are two pathways of NAD + synthesis; the de novo pathway, in which
  NAD + is synthesized from tryptophan via alpha-amino-beta-carboxy-muconate-semialdehyde
  (ACMS), quinolinic acid (QA), and nicotinic acid mononucleotide (NAMN) by quinolinate
  phosphoribosyltransferase (QPRT), and the Preiss–Handler pathway, in which NAD + is
  synthesized from nicotinic acid (NA) via NAMN by nicotinate phosphoribosyltransferase
  (NAPRT). ACMS is degraded to picolinic acid by alpha-amino-beta-carboxy-muconate-semialdehyde
  decarboxylase (ACMSD). NAM, nicotinamide; NAD + , nicotinamide adenine dinucleotide;
  NMN, nicotinamide mononucleotide; PARP, poly ADP ribose polymerase; cADPR, cyclic
  ADP ribose; NAMPT, nicotinamide phosphoribosyltransferase; NNMT, nicotinamide N-methyltransferase;
  NMNAT, nicotinamide mononucleotide adenylyltransferase; MNA, 1-methylnicotinamide;
  NNO, nicotinamide-N-oxide; 6-OHNA, 6-hydroxynicotinic acid; N-Me-2PY, N-methyl-2-pyridone-5-carboxamide;
  N-Me-4PY, N-methyl-4-pyridone-3-carboxamide; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine;
  ACMS, alpha-amino-beta-carboxy-muconate-semialdehyde; ACMSD, alpha-amino-beta-carboxy-muconate-semialdehyde
  decarboxylase; QA, quinolinic acid; QPRT, quinolinate phosphoribosyltransferase;
  NAMN, nicotinic acid mononucleotide; NA, nicotinic acid; NAPRT, nicotinate phosphoribosyltransferase.
papertitle: The significance of NAD + metabolites and nicotinamide N-methyltransferase
  in chronic kidney disease.
reftext: Rina Takahashi, et al. Sci Rep. 2022;12:6398.
year: '2022'
doi: 10.1038/s41598-022-10476-6
journal_title: Scientific Reports
journal_nlm_ta: Sci Rep
publisher_name: Nature Publishing Group UK
keywords: Medical research | Nephrology
automl_pathway: 0.9221487
figid_alias: PMC9013399__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC9013399__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9013399__41598_2022_10476_Fig1_HTML.html
  '@type': Dataset
  description: NNMT regulates NAD + and methionine metabolism. NAD + -consuming enzymes
    (Sirtuins, PARPs, cADPR synthases) degrade NAD + to NAM. NAM is converted to NMN
    by NAMPT for reuse in NAD + biosynthesis (salvage pathway). Otherwise, NAM is
    metabolized to MNA by NNMT. NNMT uses SAM as a methyl donor and yields MNA and
    SAH from NAM. N-Me-2PY and N-Me-4PY are the major final NAM metabolites. In addition
    to the salvage pathway, there are two pathways of NAD + synthesis; the de novo
    pathway, in which NAD + is synthesized from tryptophan via alpha-amino-beta-carboxy-muconate-semialdehyde
    (ACMS), quinolinic acid (QA), and nicotinic acid mononucleotide (NAMN) by quinolinate
    phosphoribosyltransferase (QPRT), and the Preiss–Handler pathway, in which NAD + is
    synthesized from nicotinic acid (NA) via NAMN by nicotinate phosphoribosyltransferase
    (NAPRT). ACMS is degraded to picolinic acid by alpha-amino-beta-carboxy-muconate-semialdehyde
    decarboxylase (ACMSD). NAM, nicotinamide; NAD + , nicotinamide adenine dinucleotide;
    NMN, nicotinamide mononucleotide; PARP, poly ADP ribose polymerase; cADPR, cyclic
    ADP ribose; NAMPT, nicotinamide phosphoribosyltransferase; NNMT, nicotinamide
    N-methyltransferase; NMNAT, nicotinamide mononucleotide adenylyltransferase; MNA,
    1-methylnicotinamide; NNO, nicotinamide-N-oxide; 6-OHNA, 6-hydroxynicotinic acid;
    N-Me-2PY, N-methyl-2-pyridone-5-carboxamide; N-Me-4PY, N-methyl-4-pyridone-3-carboxamide;
    SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine; ACMS, alpha-amino-beta-carboxy-muconate-semialdehyde;
    ACMSD, alpha-amino-beta-carboxy-muconate-semialdehyde decarboxylase; QA, quinolinic
    acid; QPRT, quinolinate phosphoribosyltransferase; NAMN, nicotinic acid mononucleotide;
    NA, nicotinic acid; NAPRT, nicotinate phosphoribosyltransferase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - QPRT
  - ACMSD
  - NMNAT1
  - NAPRT
  - NAMPT
  - STAC3
  - NNMT
  - ACOX1
  - ACSM3
  - de
  - Nmnat
  - Naprt
  - Aldox89A
  - CycE
  - cyc
  - sam
  - qkr54B
  - sls
  - Sam-S
  - sah
---
